Dr. Andrea Lorden is an independent health services research consultant who completed her doctoral studies at Texas A&M University Health Sciences Center where she was recognized with the Excellence in Research Award. With a focus on health economics and vulnerable populations, Dr. Lorden currently assists healthcare stakeholders in decisions regarding cost, quality, and access to healthcare. This includes applying epidemiological methods for disease identification, and econometric methods to identify direct and indirect costs and benefits.
Examples of Dr. Lorden’s projects include the economic evaluation of Stanford’s Chronic Disease Self-Management Program, cost-effectiveness of triple drug regimens for hepatitis C, cost-effectiveness of screening strategies for hepatitis C, the epidemiology and economic costs of Clostridium difficile and other health-care associated infections, estimates of smoking-attributable mortality and economic costs, and estimates of the life-time costs of injuries in the Native American/Alaskan Native population. Dr. Lorden also serves as a resource regarding quality metrics, informatics, and lean production technologies in healthcare.
Among her publications are numerous reports to inform government agencies, text book chapters, and peer-reviewed articles in Infection Control and Hospital Epidemiology, Quality Management Review and Evaluation & the Health Professions.
